Background: Despite years of Paediatric Antiretroviral therapy in Nigeria, the National implementation plan for the scale up of viral load testing was only rece ntly launched. Viral load determination is the most important indicator of ART response. Material & methods: First viral load samples were collected from 663 children living with HIV between December 2017-Decemb er 2019 aged 0 - 18 years on highly active antiretroviral therapy from 4 states within Nigeria. Samples were analyzed at a Polymerase Chain Reaction laboratory of the Federal Teaching Hospital Gombe. Results: Males were 311 (46.9%) and 352 (53.1%) female. Children aged 0 - 9 years constituted 44.9% (298); 55.1% (365) were aged 10 - 18 years. This first viral load was primarily routine in 94 .2% (625); 2.9% (19) of children respectively had suspected clinical or immunological failure. ART combination was AZT/3TC/NVP in 78.1% (518/663) of CLHIV; TDF/3TC/EFV in 21.2% (141); AZT/3TC/LPV/rtv in 4 (0.6%). Prior to initiation of routine viral load testing $0.55 (366/663) CLHI V had received HAART for 1 - 5 years; 7.8% (52/663) for 6 months but < 1 year; 32.8% (218/663) 6 - 10 years and 4.1% (27) for >10 years. The most recent CD4 count before viral load request was ≥1000/μL in 24.7% (164) of CLHIV; 500 - 999/μL in 42.9% (285); 350 - 499 μL in 11% (73) and <350 μL in 21.3% (141) of children. Viral load was ≥1000 c/ml in 51.3% (340/663) of children. Viral load was >1000 c/ml in 59.9% (174/311) males and 47.2% (166/352) females. Viral load was significantly lower among females (P-value 0.02). Of children aged 0 - 9 years 50.3% (150/298) had viral load > 1000 c/ml and 10 - 18 years 52.1% (190/365) (P value 0.660). Viral load was >1000 c/ml in 38.5% (20/52) of children on HAART for 6 months - 1 year and 52.2% (191/366) after receiving HAART for 1 - 5 years. 52.3% (114/218) and 55.6% (15/27) CLHIV had viral load > 1000 c/ml after receiving HAART for 6 - 10 and >10 years respectively (P value 0.29). Conclusion: About half of children on HAART have viral load > 1000 c/ml after more than 1 - 5 years on HAART. Longer duration of ART and use of AZT/3TC/NVP are associated with viral load > 1000 c/ml. Key considerations are poor adherence and/or viral drug resistance. Optimizing ART adherence and resistance monitoring remain key strategies for ART programmes.
KeywordsChildrenARTViral Load >1000 c/mlNigeria
World Health Organization (2013) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva.
Reynolds, S.J., Nakigozi, G., Newell, K., et al. (2009) Failure of Immunologic Criteria to Appropriately Identify Antiretroviral Treatment Failure in Uganda. AIDS, 23, 697-700. https://doi.org/10.1097/QAD.0b013e3283262a78
Rawizza, H.E., Chaplin, B., Meloni, S.T., et al. (2011) Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings. Clinical Infectious Diseases, 53, 1283-1290. https://doi.org/10.1093/cid/cir729
Davies, M.A., Boulle, A., Eley, B., et al. (2011) Accuracy of Immunological Criteria for Identifying Virological Failure in Children on Antiretroviral Therapy—The IEDEA Southern Africa Collaboration. Tropical Medicine & International Health, 16, 1367-1371. https://doi.org/10.1111/j.1365-3156.2011.02854.x
World Health Organization (2016) Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach.
UNAIDS (2017) 90-90-90: An Ambitious Treatment Target to Help End the AIDS Epidemic. https://www.unaids.org/en/resources/909090
Boerma, R.S., Boender, T.S., Bussink, A.P., et al. (2016) Suboptimal Viral Suppression Rates among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-Analysis. Clinical Infectious Diseases, 63, 1645-1654. https://doi.org/10.1093/cid/ciw645
Sithole, Z., Mbizvo, E., Chonzi, P., et al. (2018) Virological Failure among Adolescents on ART, Harare City, 2017—A Case-Control Study. BMC Infectious Diseases, 18, 469. https://doi.org/10.1186/s12879-018-3372-6
Havens, P.L. and Gibb, D.M. (2007) Increasing Antiretroviral Drug Access for Children with HIV Infection. Pediatrics, 119, 838-845. https://doi.org/10.1542/peds.2007-0273
Lockman, S. (2007) Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine. The New England Journal of Medicine, 356, 135-147. https://doi.org/10.1056/NEJMoa062876
Sigaloff, K.C.E., Calis, J.C.J., Geelen, S.P., van Vugt, M. and Rinke de Wit, T.F. (2011) HIV-1-Resistance-Associated Mutations after Failure of First-Line Antiretroviral Treatment among Children in Resource-Poor Regions: A Systematic Review. The Lancet Infectious Diseases, 11, 769-779. https://doi.org/10.1016/S1473-3099(11)70141-4
WHO (2018) Global Action Plan on HIV Drug Resistance 2017-2021. Progress Report. https://www.who.int/hiv/pub/drugresistance/hivdr-action-plan-2017-2021/en
Boerma, R.S., Boender, T.S., Sigaloff, K.C., et al. (2016) High Levels of Pre-Treatment HIV Drug Resistance and Treatment Failure in Nigerian Children. Journal of the International AIDS Society, 19, 21140. https://doi.org/10.7448/IAS.19.1.21140
Tadesse, B.T., Tsai, O., Chala, A., et al. (2019) Prevalence and Correlates of Pre- Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia. Viruses, 11, 877. https://doi.org/10.3390/v11090877
Abreu, J.C., Vaz, S.N., Martins Netto, E. and Brites, C. (2017) Virological Suppression in Children and Adolescents Is Not Influenced by Genotyping, But Depends on Optimal Adherence to Antiretroviral Therapy. Brazilian Journal of Infectious Diseases, 21, 219-225. https://doi.org/10.1016/j.bjid.2017.02.001
Boerma, R.S., Sigaloff, K.C., Akanmu, A.S., Inzaule, S., Boele van Hensbroek, M., Rinke de Wit, T.F. and Calis, J.C. (2017) Alarming Increase in Pretreatment HIV Drug Resistance in Children Living in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Journal of Antimicrobial Chemotherapy, 72, 365-371. https://doi.org/10.1093/jac/dkw463
Hamers, R.L., Schuurman, R., Sigaloff, K., Wallis, C.L., Kityo, C., Siwale, M., Mandaliya, K., Ive, P., Botes, M.E., Wellington, M. and Osibogun, A. (2012) Effect of Pretreatment HIV-1 Drug Resistance on Immunological, Virological, and Drug- Resistance Outcomes of First-Line Antiretroviral Treatment in Sub-Saharan Africa: A Multicenter Cohort Study. The Lancet Infectious Diseases, 12, 307-317. https://doi.org/10.1016/S1473-3099(11)70255-9
Wittkop, L., Günthard, H., De Wolf, F., Dunn, D., Cozzi-Lepri, A., De Luca, A., Kücherer, C., Obel, N., Von Wyl, V., Masquelier, B. and Stephan, C. (2011) Effect of Transmitted Drug Resistance on Virological and Immunological Response to Initial Combination Antiretroviral Therapy for HIV (EuroCoord-CHAIN Joint Project): A European Multicohort Study. The Lancet Infectious Diseases, 11, 363-371. https://doi.org/10.1016/S1473-3099(11)70032-9
World Health Organization (2015) Antiretroviral Therapy (ART) Coverage among All Age Groups. http://www.who.int/gho/hiv/epidemic_response/ART_text/en/
WHO (2014) Surveillance of HIV Drug Resistance in Adults Initiating Antiretroviral Therapy (Pre-Treatment HIV Drug Resistance). Concept Note. http://apps.who.int/iris/bitstream/10665/112802/1/9789241507196_eng.pdf?ua=1
WHO (2016) Global Report on Early Warning Indicators of HIV Drug Resistance. http://www.who.int/hiv/pub/drugresistance/ewi-hivdr-2016/en
UNAIDS. Nigeria. HIV and AIDS Estimates 2019 Country Fact Sheet.
Federal Ministry of Health (2016) National Implementation Plan for Scale-Up of Viral Load Testing in Nigeria.
Nigeria HIV/AIDS Indicator and Impact Survey (2019) National Summary Sheet Preliminary Findings.
Federal Ministry of Health (2016) National Guidelines for HIV Prevention Treatment and Care; National AIDS and STIs Control Programme.
Arpadi, S.M., Shiau, S., Gusmao, E.P.D. and Violari, A. (2017) Routine Viral Load Monitoring in HIV-Infected Infants and Children in Low- and Middle-Income Countries: Challenges and Opportunities. COMMENTARY. Journal of the International AIDS Society, 20, e25001. https://doi.org/10.1002/jia2.25001
Kenya Ministry of Health (2016) National AIDS/STD Control Programme (NASCOP) Dashboard.
Republic of Uganda (2016) Central Public Health Laboratories Viral Load Dashboard.
Tchouwa, G.T., Duverny, S.E., Cournil, A., et al. (2018) Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon. E-Clinical Medicine, 1, 21-27. https://doi.org/10.1016/j.eclinm.2018.06.005
Teasdale, C.A., Sogaula, N., Yuengling, K.A., Wang, C., Mutiti, A., Arpadi, S., Nxele, M., Pepeta, L., Mogashoa, M., Rivadeneira, E.D. and Abrams, E.J. (2018) HIV Viral Suppression and Longevity among a Cohort of Children Initiating Antiretroviral Therapy in Eastern Cape, South Africa. Journal of the International AIDS Society, 21, e25168. https://doi.org/10.1002/jia2.25168
Humphrey, J.M., Genberg, B.L., Keter, A., Musick, B., Apondi, E., Gardner, A., Hogan, J.W. and Wools-Kaloustian, K. (2019) Viral Suppression among Children and Their Caregivers Living with HIV in Western Kenya. Journal of the International AIDS Society, 22, e2527. https://doi.org/10.1002/jia2.25272
Chouraya, C., Ashburn, K., Khumalo, P., et al. (2019) Association of Antiretroviral Drug Regimen with Viral Suppression in HIV-Positive Children on Antiretroviral Therapy in Eswatini. The Pediatric Infectious Disease Journal, 38, 835-839. https://doi.org/10.1097/INF.0000000000002347
Fokam, J., Sosso, S.M., Yagai, B., Billong, S.C., Djubgang Mbadie, R.E., Kamgaing Simo, R., et al. (2019) Viral Suppression in Adults, Adolescents and Children Receiving Antiretroviral Therapy in Cameroon: Adolescents at High Risk of Virological Failure in the Era of “Test and Treat”. AIDS Research and Therapy, 16, 36. https://doi.org/10.1186/s12981-019-0252-0
Bulage, L., Ssewanyana, I., Nankabirwa, V., et al. (2017) Factors Associated with Virological Non-Suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015. BMC Infectious Diseases, 17, 326. https://doi.org/10.1186/s12879-017-2428-3
Taieb, F., Madec, Y., Cournil, A. and Delaporte, E. (2017) Virological Success after 12 and 24 Months of Antiretroviral Therapy in Sub-Saharan Africa: Comparing Results of Trials, Cohorts and Cross-Sectional Studies Using a Systematic Review and Meta-Analysis. PLoS ONE, 12, e0174767. https://doi.org/10.1371/journal.pone.0174767
Brown, K., Williams, D.B., Kinchen, S., et al. (2018) Status of HIV Epidemic Control among Adolescent Girls and Young Women Aged 15-24 Years—Seven African Countries, 2015-2017. Morbidity and Mortality Weekly Report (MMWR), 67, 29-32.
Mavhu, W., Willis, N., Mufuka, J., et al. (2020) Effect of a Differentiated Service Delivery Model Onnvirological Failure in Adolescents with HIV in Zimbabwe (Zvandiri): A Cluster-Randomised Controlled Trial. The Lancet Global Health, 8, e264-e275. https://doi.org/10.1016/S2214-109X(19)30526-1
Casale, M., Carlqvist, A. and Cluver, L. (2019) Recent Interventions to Improve Retention in HIV Care and Adherence to Antiretroviral Treatment among Adolescents and Youth: A Systematic Review. AIDS Patient Care STDS, 33, 237-252. https://doi.org/10.1089/apc.2018.0320
Enane, L.A., Vreeman, R.C. and Foster, C. (2018) Retention and Adherence: Global Challenges for the Long-Term Care of Adolescents and Young Adults Living with HIV. Current Opinion in HIV and AIDS, 13, 212-219. https://doi.org/10.1097/COH.0000000000000459
Owusu, M., Mensah, E., Enimil, A., et al. (2017) Prevalence and Risk Factors of Virological Failure among Children on Antiretroviral Therapy. BMJ Global Health, 2, A1-A67. https://doi.org/10.1136/bmjgh-2016-000260.20
Asbjornsdottir, K.H., Hughes, J.P., Wamalwa, D., Langat, A., Slyker, J.A., Okinyi, H.M., et al. (2016) Differences in Virologic and Immunologic Response to Antiretroviral Therapy among HIV-1-Infected Infants and Children. AIDS, 30, 2835-2843. https://doi.org/10.1097/QAD.0000000000001244
Ateba Ndongo, F., Texier, G., Ida Penda, C., Tejiokem, M.C., Tetang Ndiang, S., Ndongo, J.A. and Msellati, P. (2018) Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants. The Pediatric Infectious Disease Journal, 37, 78-84. https://doi.org/10.1097/INF.0000000000001745
Salou, M., Dagnra, A.Y., Butel, C., et al. (2016) High Rates of Virological Failure and Drug Resistance in Perinatally HIV-1-Infected Children and Adolescents Receiving Lifelong Antiretroviral Therapy in Routine Clinics in Togo. Journal of the International AIDS Society, 19, 20683. https://doi.org/10.7448/IAS.19.1.20683
Kanthula, R., Rossouw, T.M., Feucht, U.D., et al. (2017) Persistence of HIV Drug Resistance among South African Children Given Nevirapine to Prevent Mother-to-Child-Transmission. AIDS, 31, 1143-1148. https://doi.org/10.1097/QAD.0000000000001446
Kityo, C., Sigaloff, K.C., Boender, T.S., Kaudha, E., Kayiwa, J., Musiime, V., et al. (2016) HIV Drug Resistance among Children Initiating First-Line Antiretroviral Treatment in Uganda. AIDS Research and Human Retroviruses, 32, 628-635. https://doi.org/10.1089/aid.2015.0215
Pillay, S., Bland, R.M., Lessells, R.J., Manasa, J., de Oliveira, T. and Danaviah, S. (2014) Drug Resistance in Children at Virological Failure in a Rural KwaZulu-Natal, South Africa, Cohort. AIDS Research and Therapy, 11, 3. https://doi.org/10.1186/1742-6405-11-3
Muri, L., Gamell, A., Ntamatungiro, A.J., et al. (2017) Development of HIV Drug Resistance and Therapeutic Failure in Children and Adolescents in Rural Tanzania: An Emerging Public Health Concern. AIDS, 31, 61-70. https://doi.org/10.1097/QAD.0000000000001273
Pinoges, L., Schramm, B., Poulet, E., Balkan, S., Szumillin, E., Ferreyra, C., et al. (2015) Risk Factors and Mortality Associated with Resistance to First-Line Antiretroviral Therapy: A Multi-Centre Cross-Sectional and Longitudinal Analysis. Journal of Acquired Immune Deficiency Syndromes, 68, 527-535. https://doi.org/10.1097/QAI.0000000000000513
Cambiano, V., Bertagnolio, S., Jordan, M.R., Lundgren, J.D. and Phillips, A. (2013) Transmission of Drug Resistant HIV and Its Potential Impact on Mortality and Treatment Outcomes in Resource-Limited Settings. The Journal of Infectious Diseases, 207, S57-S62. https://doi.org/10.1093/infdis/jit111
Mbuagbaw, L., Aves, T., Borhan, S., Leenus, A., Jordan, M.J., Parkin, N., et al. (2017) Systematic Reviews and Meta-Analyses Used to Inform the on the Public Health Response to Pre-Treatment HIV Drug Resistance. Guidelines on the Public Health Response to Pre-Treatment HIV Drug Resistance. World Health Organization, Geneva.
Desta, A.A., Woldearegay, T.W., Futwi, N., Gebrehiwot, G.T., Gebru, G.G., Berhe, A.A., et al. (2020) HIV Virological Non-Suppression and Factors Associated with Non-Suppression among Adolescents and Adults on Antiretroviral Therapy in Northern Ethiopia: A Retrospective Study. BMC Infectious Diseases, 20, 4. https://doi.org/10.1186/s12879-019-4732-6
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration (2019) Incidence of Switching to Second Line Antiretroviral Therapy and Associated Factors in Children with HIV: An International Cohort Collaboration. The Lancet HIV, 6, e105-e115.
Chhim, K., Mburu, G., Tuot, S., et al. (2018) Factors Associated with Viral Non- Suppression among Adolescents Living with HIV in Cambodia: A Cross-Sectional Study. AIDS Research and Therapy, 15, 20. https://doi.org/10.1186/s12981-018-0205-z
Rangoran, S., Colby, D.J. and Truong, G.L. (2016) Factors Associated with HIV Viral Load Suppression on Antiretroviral Therapy in Vietnam. Journal of Virus Eradication, 2, 94-101. https://doi.org/10.1016/S2055-6640(20)30466-0
Obiri-Yeboah, D., Pappoe, F., Baidoo, I., Arthur, F., Hayfron-Benjamin, A., Essien-Baidoo, S., et al. (2018) Immunologic and Virological Response to ART among HIV Infected Individuals at a Tertiary Hospital in Ghana. BMC Infectious Diseases, 18, 230. https://doi.org/10.1186/s12879-018-3142-5
Dagnra, A.Y., Vidal, N., Mensah, A., et al. (2011) High Prevalence of HIV-1 Drug Resistance among Patients on First-Line Antiretroviral Treatment in Lome, Togo. Journal of the International AIDS Society, 14, 30. https://doi.org/10.1186/1758-2652-14-30
Messou, E., Chaix, M.L., Gabillard, D., et al. (2011) Association between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1-Infected Adults on Antiretroviral Therapy in Cote d’Ivoire. Journal of Acquired Immune Deficiency Syndromes, 56, 356-364. https://doi.org/10.1097/QAI.0b013e3182084b5a
Muwonga, J., Edidi, S., Butel, C., et al. (2011) Resistance to Antiretroviral Drugs in Treated and Drug-Naive Patients in the Democratic Republic of Congo. Journal of Acquired Immune Deficiency Syndromes, 57, S27-S33. https://doi.org/10.1097/QAI.0b013e31821f596c
Abioye, A.I., Soipe, A.I., Salako, A.A., et al. (2015) Are There Differences in Disease Progression and Mortality among Male and Female HIV Patients on Antiretroviral Therapy? A Meta-Analysis of Observational Cohorts. AIDS Care, 27, 1468-1486. https://doi.org/10.1080/09540121.2015.1114994
Beckham, S.W., Beyrer, C., Luckow, P., Doherty, M., Negussie, E.K. and Baral, S.D. (2016) Marked Sex Differences in All-Cause Mortality on Antiretroviral Therapy in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Journal of the International AIDS Society, 19, 21106. https://doi.org/10.7448/IAS.19.1.21106
Penot, P., He’ma, A., Bado, G., Kabore, F., Sore, I., Sombie, D., et al. (2014) The Vulnerability of Men to Virologic Failure during Antiretroviral Therapy in a Public Routine Clinic in Burkina Faso. JIAS, 17, 18646. https://doi.org/10.7448/IAS.17.1.18646
Novelli, S., Delobel, P., Bouchaud, O., et al. (2020) Enhanced Immuno Virological Response in Women Compared to Men after Antiretroviral Therapy Initiation during Acute and Early HIV-1 Infection: Results from a Longitudinal Study in the French ANRS Primo Cohort. Journal of the International AIDS Society, 23, e25485. https://doi.org/10.1002/jia2.25485
Cornell, M., Schomaker, M., Garone, D.B., Giddy, J., Hoffmann, C.J., Lessells, R., et al. (2012) Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study. PLoS Medicine, 9, e1001304. https://doi.org/10.1371/journal.pmed.1001304
De Beaudrap, P., Thiam, M., Diouf, A., Toure-Kane, C., Ngom-Gueye, N.F., Vidal, N., et al. (2013) Risk of Virological Failure and Drug Resistance during First and Second-Line Antiretroviral Therapy in a 10-Year Cohort in Senegal: Results from the ANRS 1215 Cohort. Journal of Acquired Immune Deficiency Syndromes, 62, 381-387. https://doi.org/10.1097/QAI.0b013e31827a2a7a
Datay, M.I., Boulle, A., Mant, D. and Yudkin, P. (2010) Associations with Virologic Treatment Failure in Adults on Antiretroviral Therapy in South Africa. Journal of Acquired Immune Deficiency Syndromes, 54, 489-495. https://doi.org/10.1097/QAI.0b013e3181d91788